AXL and sarcoma: The relative lack of objective response in the sarcoma cohort is likely due to the aggressive nature of the disease and intrinsic resistance of the tumor cells to tubulin-targeting payloads, including MMAE (34), that could not be overcome despite the increased payload delivery facilitated by high tumoral AXL expression.